Cleared Traditional

K834059 - FUKUDA DENSHI EH-11

K834059 is the FDA 510(k) clearance for FUKUDA DENSHI EH-11 by Fukuda Denshi USA, Inc.. It is a Class 2 Cardiovascular device (product code DXG) cleared through the Traditional 510(k) pathway after a 574-day FDA review.

K834059 · Fukuda Denshi USA, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1985
Decision
574d
Days
Class 2
Risk

K834059 is an FDA 510(k) clearance for the FUKUDA DENSHI EH-11. Classified as Computer, Diagnostic, Pre-programmed, Single-function (product code DXG), Class II - Special Controls.

Submitted by Fukuda Denshi USA, Inc. (Walker, US). The FDA issued a Cleared decision on June 21, 1985 after a review of 574 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1435 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Fukuda Denshi USA, Inc. devices

Submission Details

510(k) Number K834059 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 25, 1983
Decision Date June 21, 1985
Days to Decision 574 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
449d slower than avg
Panel avg: 125d · This submission: 574d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXG Computer, Diagnostic, Pre-programmed, Single-function
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1435
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXG Computer, Diagnostic, Pre-programmed, Single-function

All 84
Devices cleared under the same product code (DXG) and FDA review panel - the closest regulatory comparables to K834059.
MODEL SP1465 CARDIAC OUTPUT COMPUTER
K861092 · Gould, Inc. · Aug 1986
ARRHYTHMIA REVIEW STATION
K854136 · Marquette Electronics, Inc. · Dec 1985
DESERET THERMODILUTION CARDIAC OUTPUT
K841967 · Parke-Davis Co. · Aug 1985
CRITIKON CARDIAC OUTPUT COMPUTER W/HEMODYNAMIC
K844116 · Critikon Company, LLC · May 1985
MODEL 78231D CARDIAC OUTPUT MODULE
K850568 · Hewlett-Packard Co. · Apr 1985
ELECATH CARDIAC OUTPUT COMPUTER
K844682 · Electro-Catheter Corp. · Mar 1985